Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3924_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
1
Добавлен:
10.10.2026
Размер:
8 Мб
Скачать
☆
294 Brachiocephalic interventions
is a stenosis or occlusion near the origin of the le
subclavian artery. e planning varies depending
on whether the lesion is on the patient’s right or le
side and whether it is located at the origin of the
artery or a location more distal.
Transfemoral approach to the
subclavian and axillary arteries
A 6-Fr or 7-Fr sheath is placed in the femoral
artery. Arch aortography is performed to iden-
tify the location of the subclavian artery. Very
oen, if the lesion is near the origin of the le
subclavian artery, it can also be located by look-
ing for its positional variation with pulsatility,
while observing with uoroscopy. If the lesion
is on the patient’s le side, a LAO projection is
best. If the lesion is on the patient’s right side, the
innominate artery is cannulated and a RAO pro-
jection performed to identify the location of the
right subclavian artery origin. Heparin is admin-
istered (75–100 U/kg). AGlidewire
®
is placed in
the aortic arch in exchange for the ush catheter.
An angled catheter, usually 100 cm in length with
a simple curve tip, such as a vertebral catheter, is
placed over the Glidewire
®
. If the origin of the
artery is relatively free of disease, the catheter is
used to cannulate the subclavian artery and the
Glidewire
®
is advanced. If there is a signicant
lesion at the origin of the subclavian artery, the
catheter is used to direct the Glidewire
®
toward
the artery orice. e Glidewire
®
is used to
probe the lesion with the intent of crossing it. If
the lesion at the origin of the subclavian artery is
very challenging to traverse with this relatively
unstable platform, another approach is as follows.
A 6-Fr or 7-Fr, 70-cm or 90-cm long, straight
sheath with a radiopaque tip is passed and the tip
advanced to within a few centimeters of the orice
of the subclavian artery. e dilator is removed
and the appropriate selective cerebral catheter
(see Chapter 9), 100–120 cm in length, is placed
through the sheath. e tip of the selective cath-
eter is placed beyond the end of the sheath. e
steerable guidewire probes the orice of the artery
with support and direction provided by the selec-
tive catheter. e guidewire is advanced across
the lesion and as far into the artery as possible to
provide support for the catheter to be advanced
(Figure 21.11). e catheter is advanced into the
subclavian artery. Selective arteriography may be
performed if necessary. A stier guidewire, such
as an Amplatz Super Sti
®
or other exchange wire,
is placed. e selective catheter is removed, the
dilator placed, and the sheath advanced into the
artery origin. Arteriography and heparin ush
administration is performed through the side arm
of the sheath.
e best lesions for angioplasty and stenting in
this area are short and located well proximal or
distal to the vertebral artery. A lesion juxtaposed
to the vertebral artery might be better treated
with open surgery. e endovascular option usu-
ally involves stent placement in the vertebral and
subclavian arteries. e balloon diameter is usu-
ally between 6 and 8 mm. e balloon catheter is
placed across the lesion. e balloon is inated and
resolution of the atherosclerotic waist is observed
using uoroscopy. Oen the location of the origin
of the subclavian artery can be visualized during
balloon ination. Because the subclavian artery is
so and a rupture in this location has potentially
disastrous consequences, it is important to avoid
overdilation. Subclavian artery orice lesions are
usually treated with balloon-expandable stents
since these lesions are oen heavily calcied and
spillover lesions from the aortic arch and the artery
are relatively xed in position at this site. Lesions
in more distal locations are best treated with self-
expanding stents, since the artery is more exible
and mobile in these areas and may be aected by
external structures and forces. Stents should be
avoided near the crossing of the rst rib and distal
to the humeral head since these are areas of very
high exibility and with potential for external
impingement.
Stent placement considerations in the subcla-
vian artery are similar to those for the common
carotid artery. Aer angioplasty, if the sheath is
in a stable position for stent placement, it is le in
position. If the position is a bit unstable, the tip of
the sheath can be advanced a centimeter, or a few
centimeters, over the actively deating balloon in
order to get the sheath into a slightly more stable
position prior to stent placement. A premounted
stent on the appropriately sized balloon with a
90–120-cm sha length is used for orice lesions
(Figure 21.11). e balloon-expandable stent size
for the proximal common carotid artery is usually
6–8 mm. e balloon and stent are passed through
the sheath and across the lesion and the stent is
deployed. Advancing the sheath across the lesion
https://t.me/med1917
The subclavian and axillary arteries 295
for stent delivery is usually not necessary as long as
the sheath tip has a secure purchase on the artery
origin and the lesion has been predilated enough
to permit passage of the catheter. Self-expanding
stents are more likely to be used in the subclavian
artery, when the lesion is distal to the origin, and
also in the axillary artery. e self-expanding stent
diameter should be 8 or 10 mm and the delivery
catheters are 120 cm in length. e delivery cath-
eter is passed through the sheath and across the
lesion, and the stent is deployed. Poststent balloon
angioplasty is performed. Completion arteriogra-
phy is performed through the sheath.
Lesions at the orice of the subclavian artery
pose similar challenges to those that occur at the
common carotid artery origin. When the sheath is
withdrawn to expose the stent, the tip of the sheath
loses its purchase on the artery. When treating this
type of lesion from a transfemoral approach, pull
the sheath back slowly and place its tip in the arch
but close to the origin of the artery. Another option
is to place the stent through a retrograde, transbra-
chial approach.
If the lesion extends to the vertebral artery, care
must be taken when deploying stents at this loca-
tion as the origin of the vertebral artery is at risk
for injury. is is also a location in the subclavian
artery where there is some signicant curvature.
A self-expanding stent may potentially be use-
ful when the lesion is distal to the origin and in a
tortuous segment of the artery. Avoid choosing a
stent that is too long; a calibrated catheter is useful
for this. To obtain the best view of the origin of the
vertebral artery, sometimes it proceeds directly
from the superior aspect of the subclavian artery but
sometimes also it comes o the posterior aspect of
the subclavian artery. A slight craniocaudal angula-
tion (5–10 degrees) may help visualize the vertebral
artery origin. Aer placement of a self-expanding
stent, the balloon may be gradually upsized so that
A
B C
D
E F
Fig. 21.11 Balloon angioplasty and stenting of the subclavian artery through a transfemoral approach.
(A) A guidewire is placed in the subclavian artery and across the lesion. (B) A long sheath is placed
with its tip in or near the origin of the subclavian artery. An angioplasty catheter is placed. (C)Balloon
angioplasty of the subclavian artery lesion is performed. (D) The stent is delivered to the site of
the lesion. (E) Stent deployment is performed. Caution is exercised during stent deployment to
avoid engaging the tip of the sheath with the stent and deployment in proximity to the origin of the
vertebral artery. (F) Completion arteriography is performed through the sheath.
https://t.me/med1917
296 Brachiocephalic interventions
the artery is gently dilated and the risk of rupture
is diminished. If the brachial approach is chosen,
the catheter is advanced from the brachial side of
the lesion and there is only really one place for this
guidewire and catheter system to go, and that is ret-
rograde directly into the lesion.
Retrograde approach to the
subclavian and axillary arteries
e transbrachial or transradial, retrograde
approach to the subclavian and axillary arteries is
direct and does not require selective catheteriza-
tion from as remote an entry site as does the trans-
femoral approach (Figure 21.12). e patient’s
ipsilateral arm is extended at the side. A work-
ing table is placed at the end of the arm board to
accommodate the guidewires and catheters. e
transbrachial approach may be performed through
either an open exposure of the artery or a percuta-
neous puncture.
e guidewire is advanced retrograde using u-
oroscopy. A 6-Fr sheath is usually required, either
30 cm or 45 cm in length. It is sometimes useful to
place a longer sheath, depending on the location of
the lesion, and to perform retrograde arteriogra-
phy through the side arm of the sheath. Heparin is
administered. e guidewire is advanced through
the lesion. When the lesion of interest is at or near
the origin of the subclavian artery, it is usually
best to place a pigtail catheter through the femoral
artery and perform arch aortography using a pres-
sure injector. Retrograde arteriography through
a short sheath is usually not possible. Aer the
guidewire is advanced across the lesion, a straight
catheter with multiple side holes may be advanced
over the wire until its tip is proximal to the lesion,
and this catheter may be used for arteriography.
If the lesion is proximal to the vertebral artery,
the guidewire must be advanced into the descend-
ing aorta to maintain adequate control at the inter-
vention site. e guidewire is directed into the
descending thoracic aorta using a selective cath-
eter with a bend at the tip. A balloon catheter with
a 75-cm sha is placed and the balloon inated.
Stenting of the orice of the subclavian artery
should be performed with a balloon-expandable
stent. A premounted balloon-expandable stent is
advanced to the origin of the artery and deployed.
Tortuous segments of the artery can be stented
with self-expanding stents, as with the transfemo-
ral approach. e sha length for self-expanding
or balloon-expandable stents through a brachial
approach is 80 cm.
Occasionally, when the lesion is juxtaposed to
the vertebral artery and an endovascular option is
better than a carotid–subclavian bypass, a subcla-
vian artery stent can be placed through a femoral
artery access and a wire and/or distal lter placed
in the vertebral artery using a brachial approach.
A B C D
Fig. 21.12 Balloon angioplasty and stenting of the subclavian artery through a transbrachial approach.
(A) A guidewire and sheath are placed through a brachial artery puncture or cutdown. (B) A balloon
catheter is advanced through the sheath and into the lesion and balloon angioplasty is performed.
(C) The balloon is withdrawn. (D) Stent placement is performed. (E) Completion arteriography is
performed using a retrograde approach through the sheath.
https://t.me/med1917
297
22
Visceral and renal artery interventions
APPROACH TO THE VISCERAL
ARTERIES
e operator must decide whether to approach the
visceral arteries through a femoral access or an upper
extremity access. e advantages of the femoral
access are that it is commonly performed, clinicians
are comfortable with the procedure, and closure
devices may be used. e development of options for
an articulated sheath has made access from an infe-
rior direction simpler for treatment of downsloping
vessels such as the superior mesenteric artery (SMA).
When the downsloping angle is severe, it may make
more sense to come from a radial artery or brachial
artery access. e distance is slightly longer, but
passage of a crossing wire and placement of a stent
become simpler when the direction of the platform
is consistent with the overall direction of the visceral
vessel being treated. In some patients, the anatomy
along the access route can be hostile. If the infra-
renal aorta or the supraceliac aorta is severely dis-
eased, this may aect the decision about which way
to approach the visceral vessels. Preoperative CTA
can be used to help make this decision. e trajec-
tory of each of the vessels on these imaging studies
can be assessed. A6.5-Fr articulating sheath, which
allows the sheath tip to be manipulated into various
degrees of curvature, is available. is is quite help-
ful in supporting visceral and renal artery treatment
since these vessels come o the aorta at an angle.
CELIAC AND SUPERIOR
MESENTERIC ARTERY
ANGIOPLASTY AND STENTING
Visceral artery stenoses or occlusions may be visu-
alized by CTA. Many are asymptomatic, but when
accompanied by abdominal pain or other signs of
visceral ischemia, they may requi re urgent treatment.
A visceral artery lesion identied on angiography
oen appears longer than it actually is. An occlusion
or stenosis usually starts at the origin of the artery
and the precise location of the origin can some-
times be dicult to identify during the procedure.
Frequently, there are hints as to where the origin of
the artery is located or if there is a beak of contrast
or a signicant amount of calcication in the area
where the artery is located. During cannulation of
the visceral arteries, imaging is best conducted with
the C-arm in a straight lateral position. e position
of the arms is problematic since in the straight lat-
eral imaging position, the upper extremities inter-
fere with the uoroscopic image. Sometimes, a steep
oblique is adequate to visualize the origins of the vis-
ceral arteries. If a lateral position of the image inten-
sier is required, the arms can be stretched above the
patient’s head or they can rest over the anterior chest
and abdomen. Balloon-expandable stents are gen-
erally used to treat these lesions since they usually
occur at the origin of the artery.
is procedure may be approached from either
a transfemoral route or a transbrachial route, as
described above (Figure 22.1). e angles for can-
nulating a ush occlusion of the SMA are fairly
unfavorable from a transfemoral route. e celiac
artery trajectory from the aorta may be perpendic-
ular, or nearly so, and if this is the case, there is no
particular advantage to one or the other approach
to an occlusion. However, if the artery is patent but
stenotic or if there is a beak of entry contrast into
the artery, then it may be possible to cannulate it
from either direction. It is usually a good idea to
undertake a preprocedure study, such as CTA,
which will indicate the location and severity of
visceral artery occlusive disease. In addition, a full
array of angle tip delivery sheaths or guide catheters
https://t.me/med1917
298 Visceral and renal artery interventions
and premounted, balloon-expandable stents should
be available, including low-prole systems.
Systemic anticoagulation is administered.
A ush paravisceral aortogram is obtained. e
location of the origin of the visceral vessel of inter-
est is identied. A sheath is placed, which is usu-
ally 6-Fr in diameter, and this sheath may have an
angled tip, a curved or renal double curve (RDC)
shape, or it may be straight. e length of the sheath
must be adequate so that the tip of the sheath is
near the origin of the vessel. If a challenging angle
is present during a transfemoral approach, consider
using a curved sheath or guiding catheter such as
a RDC or inferior mesenteric artery (IMA) shape.
From the brachial route, a straight or hockey stick-
shaped sheath tip is used. Aer sheath placement,
the appropriately curved or angled 4-Fr or 5-Fr
catheter is placed (Figure 22.2).
e advantage of a more dramatically curved
catheter is t hat it gives more angulation to the trajec-
tory of the guidewire as attempts are made to can-
nulate an aortic side branch with an abrupt angle.
e disadvantage of the more curved catheter is
that as the guidewire enters the lesion, the catheter
may buckle in an unfavorable way and create insta-
bility in the system. A catheter that is well shaped
to cannulate may be dierent from one that is well
shaped to follow. If the origin of the artery is identi-
able and open, the catheter is used to cannulate it.
If there is a ush occlusion, the catheter and sheath
are used to support the wire as it is used to probe
for the opening through the lesion. Sometimes, a
0.014-inch guidewire with the lowest possible pro-
le is required for this task. Aer the guidewire is
in place, the catheter must be exchanged out, and
in this setting the curvature in the catheter may
attempt to drag the wire out of the artery. e
artery may be cannulated using either a 0.014- or
0.035-inch steerable guidewire. Choose the catheter
with the least amount of curve needed to make the
gap from the tip of the sheath to the origin of the
diseased artery. Oen, it becomes apparent that
it is helpful to withdraw the sheath a little bit to
allow the catheter to take its full shape and have a
full degree of mobility when attempting to cannu-
late the artery. If it transpires that this position is
Fig. 22.1 Considerations for proxi-
mal versus distal approach to the
visceral arteries. (A) A lateral view
of the celiac and superior mesen-
teric arteries is demonstrated. In
patients with standard anatomy, the
sheath approach can be either from
a proximal or distal direction. (B) In
situations where the visceral arteries
have an acute angle of origin from the
aorta, with a severely downsloping
trajectory, a proximal approach may
make the entire procedure simpler.
(C) When the thoracic aorta or supra-
celiac aorta is severely diseased or
aneurysmal, or has significant mural
thrombus associated with it, it is usu-
ally safer to approach the visceral ves-
sels from an inferior direction. (D) In
situations where the infrarenal aorta is
severely diseased and there is a large
amount of pararenal atherosclerosis
or mural thrombus, it is usually safer
to approach the visceral vessels from
a proximal direction through an upper
extremity access.
A
B
C
D
https://t.me/med1917
Celiac and superior mesenteric artery angioplasty and stenting 299
not supportive enough, usually the sheath can be
advanced directly over the catheter with the guide-
wire in it and protruding. e “no touch” technique
is frequently employed when an artery origin lesion
is present. When the lesion is slightly farther from
the origin of the artery so that there is a stump of
relatively nondiseased vessel, cannulation is usu-
ally a simpler procedure. e opening of the artery
is cannulated with the catheter rst and then the
wire is placed through that location. Once the wire
is in the lesion, care must be taken as the lesion is
being crossed not to catch the wire on any undesir-
able locations or create a subintimal channel. Keep
in mind that the shape of the catheter will change
as a longer distance of guidewire and a stier por-
tion of the wire is passed through the lesion and
also through the catheter head. Once the guidewire
is across the lesion, the same catheter can usually
be used to exchange for a more favorable guidewire
with which to perform the stent placement. As in
the case of other aortic branch lesions, the celiac
artery and SMA can be treated using either a 0.035
system or a lower-prole system (i.e., 0.014- or
0.018-inch diameter system).
e advantage of the 0.014-inch diameter system
is that the sheath required is not quite as large and
despite using a 6-Fr sheath or even a 5-Fr sheath,
you can consistently obtain interim angiographic
images by injecting contrast through the side arm
of the sheath and around the treatment catheters.
e other advantage of the small caliber system is
that low-prole balloons and stents are more likely
to make any sharp turns in the access sheath and
pass across the lesion since they are so much lower
prole. e 0.035 systems frequently require pre-
dilation in order to pass the stent into the lesion.
e advantage of the 0.035 system is that it can be
used with a larger and very sti guidewire, which
can make the whole system, including the guiding
sheath or guiding catheter, quite a bit more stable.
e wire length accommodated by the celiac artery
is usually shorter than the SMA. e celiac artery
and its branches are shorter and a lot more tortu-
ous. Aer feeding a certain length of guidewire into
a tortuous artery, there is usually a build-up of ten-
sion and eventually push back against the wire. In
the SMA, there is usually a relatively lengthy seg-
ment distal to the lesion. is makes the system
more stable. However, the usually fairly severe angle
of origin from the aorta increases the tension and
makes the system comparatively a little less stable.
Once the guidewire is across the lesion, care
must be taken to ensure that it is actually in the cor-
rect location. Even if it is in the correct artery, care
must be taken to ensure that it has not gone into
some small branch or collateral branch out of the
main artery just distal to the lesion. With regard to
the SMA, a le anterior oblique (LAO) projection is
oen best to follow the guidewire since the artery
tends to extend anteriorly and toward the right at
its root. With regard to the celiac artery, a straight
lateral or steep oblique is usually best to follow the
wire, but a substantial amount of image quality
is lost in doing this since you are shooting X-rays
through the wider part of the person from one side
laterally to the other. e wire going into the SMA
can extend for many centimeters distal to the lesion
and into the distal SMA, and this can provide a
fairly good rail over which to work (Figure 22.3).
An alternative method of access is demon-
strated in Figure 22.4. Steerable guide sheaths are
available that signicantly improve the ability to
place a sheath into an inferiorly slanting visceral
A B
Fig. 22.2 Catheterization of the celiac and supe-
rior mesenteric arteries. (A) A hook-shaped cath-
eter is selected. The image intensifier is placed in
the lateral or near lateral position. Thecatheter
tip is used to engage the orifice of the artery.
A 0.035-inch Glidewire
®
or a low- profile guide-
wire (0.018 or 0.014 inch) is advanced. The celiac
artery is usually short and the guidewire tip
usually finds an early branch of the artery and
follows a curving path. Guidewire placement in
the SMA usually follows a straighter, diagonal
and downward course. (B) After the catheter tip
is engaged and the wire advanced, the catheter
shaft is withdrawn slightly and the tip usually
engages and slides into the visceral artery.
https://t.me/med1917
300 Visceral and renal artery interventions
A B C
D E
Fig. 22.3 Stenting of a superior mesenteric artery lesion. (A) The guiding sheath or catheter is
advanced so that its tip is in proximity to the SMA. A hook-shaped angiographic catheter is placed.
(B) A 0.014-inch guidewire is advanced. The angiographic catheter is used to support and direct
the guidewire. (C) The catheter is removed. The guidewire is advanced into a stable position.
(D)A premounted, low-profile, balloon-expandable stent is advanced directly into the lesion.
(E)Thestent is placed at the orifice of the artery.
Fig. 22.4 Use of a steerable guide sheath to access the superior mesenteric artery. Shown is a 6.5-Fr
sheath that offers the operator the opportunity to control the shape of the sheath in one direction,
providing angulation on the basis of a control knob.
https://t.me/med1917
Celiac and superior mesenteric artery angioplasty and stenting 301
vessel using a femoral approach. e steerable
guide sheath may also be used in the same manner
when approaching the renal arteries.
e celiac artery has some technical dier-
ences that distinguish it from the SMA. e artery
begins to make turns immediately aer its origin.
It is not at all uncommon to place the guidewire
within the celiac artery and for it to be only within
the artery for a few centimeters before it encoun-
ters resistance due to the tortuosity of the branches
of the artery. e celiac artery is usually quite short
and this requires great accuracy in placing stents.
e celiac artery also usually has an early branch
point with an abrupt change in caliber and is more
likely than the SMA to exhibit poststenotic dila-
tion. ere is usually no available length of celiac
artery in which the access sheath can be seeded.
Try to choose the best celiac artery branch to pro-
vide stability. Once the guidewire is in place, the
right length and diameter of stent must be selected
and placed in the right spot so that the trailing
end of the stent is ush with the aorta or protrud-
ing slightly into the aorta so that the entire lesion
may be treated. Because the celiac artery is oen
so short, the lesion may be the whole length of the
celiac artery, with branches immediately distal to
that. Usual stent lengths in the celiac artery are
12–18 mm, rarely longer. e usual stent diameter
is 6–8 mm. Aer stent placement, follow up with
poststent angioplasty. If the artery is very short
and the distal end of the lesion is very close to
the branches, it is occasionally necessary to place
a couple of guidewires into dierent celiac artery
branches. SMA treatment likewise has its nuances.
Passage of the stent through the bend from the
aorta into the SMA is sometimes dicult. e
combination of the angle and a tight lesion make
it more likely than the celiac artery to require pre-
dilation prior to stent placement. Poststenotic dila-
tion is less likely but can denitely happen and the
stent should not be matched to this diameter. SMA
stents are typically balloon-expandable and are
usually a little longer; up to 3 cm is not unusual.
e common diameters range from 6 mm to 8 mm.
ere are challenges in stent placement in the
visceral segment. Fluoroscopic image clarity is
diminished because of the depth of the location
and the thickness of the tissue that must be pen-
etrated. ere is a continuous movement of vascu-
lar structures. Bowel gas oen obscures the target
site. is is an area where heavy calcications may
occur, especially along the anterior wall at the ori-
gins of the visceral arteries and sometimes along
the posterior wall, where it is desirable to avoid
embolization by disrupting this material. If there
is a severe angle of exit from the aorta, and espe-
cially if it is a SMA or there is signicant infra-
renal pathology, then a transbrachial approach is
more desirable. It is usually best to place the tip of
the delivery sheath either inside the origin of the
artery or very close to it to support treatment.
Covered stents may also be used for treatment of
the celiac artery and SMA. ere are some data to
suggest that the patency of covered stents is better
than that of bare metal stents. ere are some low-
prole balloon-expandable covered stents that can
be used, ranging from 5 cm to 7 cm. e expected
foreshortening is a little less than with bare metal
stents. One potential advantage of covered stents is
that they remove one mechanism of intimal hyper-
plastic recurrent stenosis through the open spaces
between the struts of the stent. ere are two poten-
tial disadvantages. One is that the gra material
takes up some of the lumen. e other is that some
arteries have early branches. is is especially true
of the celiac artery, and in these situations, coverage
of branch arteries is not desirable.
If performing a transbrachial approach, place a
4-Fr access sheath in the le brachial artery using a
micropuncture needle and a 4-Fr sheath. Aerplace-
ment of a 4-Fr sheath, administer systemic antico-
agulation. A 90-cm Omni
®
Flush catheter is passed
along with a Glidewire
®
. In the arch of the aorta, the
Omni
®
Flush catheter is turned posteriorly and used
to direct the guidewire into the descending aorta.
e image intensier is placed in the LAO position
for this maneuver. e ush catheter is advanced
and a visceral aortogram obtained. e approximate
distance to the lesion is estimated against the length
of the catheter. A sti guidewire is passed through
the catheter and the catheter is removed. e 4-Fr
sheath is removed from the arm, dilators are used,
and then a long 6-Fr sheath is placed so that the tip of
the sheath is in the aorta near the target lesion. Once
the 6-Fr sheath is placed in the appropriate location,
oblique projections of the SMA and celiac artery can
be obtained and an angle tip, long catheter, such as
a 125-cm length 5-Fr vertebral catheter, is placed.
Aer placement of the catheter, it becomes apparent
where the tip of the sheath needs to be and the sheath
is withdrawn slightly as needed. It is not possible at
this point to advance the sheath on its own without
https://t.me/med1917
302 Visceral and renal artery interventions
the dilator and the sti guidewire and, therefore, it is
inserted beyond the point that is required and then
slightly withdrawn when the time comes. By pointing
the angle tip catheter toward the origin of either the
celiac artery or the SMA, whichever requires treat-
ment, the guidewire may then be advanced from the
tip of the catheter. e shape of the aorta oen causes
a rotational bias in the sheath. When this happens it
may point toward the lesion intended for treatment or
it may point away.
e same steps are followed as described above
when using the transfemoral route to accomplish
stent placement, with the obvious dierence of
length requirements. e major dierence in the
transfemoral route is that access site management
is a little simpler but the actual access to the visceral
artery for stenting is oen more complex due to
angulation. is is because of the extreme angles of
origin of some visceral arteries. Aer the sheath is
placed and the lesion is crossed, the sheath and the
guidewire may try to pop out during the procedure.
RENAL ANGIOPLASTY AND
STENTING
e technique of renal angioplasty and stent-
ing has been greatly simplied by the introduc-
tion of the 0.014-inch diameter systems in renal
revascularization. e renal arteries are usually
approached retrograde using a femoral access, but
an antegrade approach through a brachial puncture
site or radial access may occasionally be used when
the angle of the renal artery takeo from the aorta
is narrow or when severe aortoiliac disease prohibits
catheterization of this segment. Renal revasculariza-
tion may also be performed using an IMA-shaped
guiding catheter, with the use of a manifold device
and also the possibility of a distal protection device.
A detailed discussion of renal artery catheteriza-
tion can be found in Chapter 9. Information about
aortorenal and selective renal arteriography can be
found in Chapter 11. Supplies required for renal
artery intervention are listed in Table 22.1.
In deciding whether to treat a renal artery from
the transfemoral route or the transbrachial route,
there are a few considerations. Most of the time it
is fairly straightforward to treat a renal artery ste-
nosis from a transfemoral route. e distance is
shorter, the imaging is simpler, and the procedure
is overall safe and reliable. One disadvantage of
the transfemoral route is that there may be some
associated infrarenal aortic pathology, such as an
abdominal aortic aneurysm, mural thrombus or
atherosclerosis, or other lesion, which may substan-
tially inuence the safety of the case. If there is sig-
nicant iliac tortuosity, this will bias the catheter
Table 22.1 Supplies for renal artery intervention
Length Diameter
Guidewire Starting guidewire Bentson 145 cm 0.035 inch
Selective guidewire Magic torque 180 cm 0.035 inch (marker tip)
Grand Slam 180 cm 0.035 inch (angled tip)
Catheter Exchange guidewire Rosen 180 cm 0.014 inch (soft tip)
Flush catheter Omni
®
Flush 65 cm 5-Fr
Selective catheter Cobra C1, C2 65, 80 cm 5-Fr
Renal double curve 65, 80 cm 5-Fr
Renal curve 1, 2 65, 80 cm 5-Fr
SOS Omni
®
2 80 cm 5-Fr
Sheath Selective guide sheath Destination
®
angled 45 cm 6-Fr, 7-Fr
Renal double curve 55 cm 5-Fr
Balloon Balloon angioplasty catheter Balloon diameter 4, 5, 6, 7 mm
Balloon length 2, 4 cm
Catheter shaft 75 cm
Stent Balloon-expandable stent
(premounted– 0.014inch)
Stent diameter 5, 6, 7 mm
Stent length 12–29 mm
Shaft length 80 cm
https://t.me/med1917
Renal angioplasty and stenting 303
or sheath toward one side or the other and create
extra challenge. is may work to your favor if this
is the side you are treating; however, it may work
aggressively against you and serve to turn the cath-
eter and/or sheath to the opposite side to which you
desire throughout the procedure. Another situation
in which it is helpful to abandon the transfemoral
route and go with the transbrachial or transradial
route is when there is a severe and acute angle of
takeo of the renal artery so that it is signicantly
downsloping, similar to a SMA. Although this
is usually possible to do through a transfemoral
route, having a critical or even preocclusive lesion
near the origin of the renal artery is sometimes
extremely dicult to cannulate when coming from
the transfemoral route. e combination of a criti-
cal lesion that must be crossed and a severe angu-
lation at nearly the same location can make access
and stability of the platform challenging. Aer the
guidewire is across the lesion, the more angulated
the approach, due to the curvature imposed by the
turn from the aorta into the renal artery, the less
stable the system and the less pushability and track-
ability the operator has. Usually, a low-prole sys-
tem using an 0.014- or 0.018-inch platform works
best. A low-prole system also facilitates the possi-
bility of using a rapid exchange system and primary
stenting with fewer exchanges.
Aer retrograde femoral puncture, the guidewire
is passed to t he level above the upper abdominalaorta.
A 4-Fr or 5-Fr ush catheter is placed and the guide-
wire removed. e catheter head is placed at the junc-
tion of the rst and second lumbar vertebral bodies. It
is best to perform a complete aortoiliac arteriography
if renal function permits. is allows accessory renal
arteries and other variations to be identied, as well
as disease that is present along the approach to the
renal arteries. e operator then knows where other
disease is located that may potentially cause compli-
cations during intervention. Aer this is performed,
a magnied view of the aorta and renal artery origins
should be obtained. e image intensier usually
has an oblique orientation slightly toward the side of
probable intervention. Aer the image intensier is
optimally located, it is usually best to leave it in that
position until aer the artery is cannulated.
The renal arteries are unique in terms of their
mobility with breathing. The origins of the renal
arteries are relatively fixed in place bythe dia-
phragmatic crus. The renal parenchyma and
surrounding tissues within Gerota’s fascia are
mobile with diaphragmatic excursion. The result
of this anatomic arrangement is that the angle
of takeoff of the renal arteries from the aorta
varies with the ventilatory cycle. The anatomic
picture portrayed varies depending on how the
diaphragm was held during the arteriography.
Afully held breath tends to accentuate the acute
angle at the origin of the renal artery by pushing
the kidney caudad (Figure 22.5). Because the
L1
L2
L1
L2
L1
L2
A B C
Fig. 22.5 Renal artery position is dependent on diaphragmatic motion. (A) At full exhalation, the kidney
position is high in the retroperitoneum and the angle at the renal artery origin is affected accordingly.
(B) During mid-inhalation, the angle of takeoff at the renal artery origin becomes more acute. (C) At full
inspiration, the renal artery origin is at an even more acute angle.
https://t.me/med1917